Pharmabiz8h
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam
FABA inks MoU with Thu Dau Mot University to set up FABA chapter in Vietnam: Our Bureau, Bengaluru Wednesday, September 25, ...
Pharmabiz13h
Health ministry notifies Rules to register CROs under NDCTR, 2019
Health ministry notifies Rules to register CROs under NDCTR, 2019: Gireesh Babu, New Delhi Wednesday, September 25, 2024, ...
Pharmabiz4h
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age: Tokyo Wednesday, September 25, ...
Pharmabiz3h
Theriva achieves target patient enrollment in VIRAGE phase 2b trial of VCN-01 with gemcitabine/nab-paclitaxel to treat metastatic pancreatic cancer
Rockville, Maryland Wednesday, September 25, 2024, 18:00 Hrs [IST] ...
Pharmabiz4h
Experts highlight urgent need for novel anti-infectives at the 7th Annual National Conference by Society of Neurocritical Care of India
Our Bureau, Mumbai Wednesday, September 25, 2024, 17:50 Hrs [IST] ...
Pharmabiz4h
LEO Pharma’s Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
Ballerup, Denmark Wednesday, September 25, 2024, 17:00 Hrs [IST] ...
Pharmabiz4h
Emmes awarded multi-task, IDIQ contract
Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA [National Institute of ...
Pharmabiz4h
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence: Our Bureau, Bengaluru Wednesday, September 25, 2024, 17:40 Hrs [IST] Narayana Health, unveiled fir ...
Pharmabiz5h
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer: Osaka, Japan Wednesday, September 25, 2024, 16:30 Hr ...
Pharmabiz6h
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis: Austin, Texas Wednesday, September 25, 2024, 15:00 Hrs ...
Pharmabiz5h
NIH awards $27 million to establish new network of genomics-enabled learning health systems
NIH awards $27 million to establish new network of genomics-enabled learning health systems: Bethesda, Maryland Wednesday, September 25, 2024, 16:00 Hrs [IST] The National Institu ...
Pharmabiz7h
Joint WHO Europe-FIP high-level dialogue raises awareness of pharmaceutical services among policymakers
Joint WHO Europe-FIP high-level dialogue raises awareness of pharmaceutical services among policymakers: Our Bureau, Bengaluru Wednesday, September 25, 2024, 14:15 Hrs [IST] World ...